pre-miRNA Information | |
---|---|
pre-miRNA | hsa-mir-3150b |
Genomic Coordinates | chr8: 95072911 - 95072996 |
Description | Homo sapiens miR-3150b stem-loop |
Comment | None |
RNA Secondary Structure |
Mature miRNA Information | |||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Mature miRNA | hsa-miR-3150b-3p | ||||||||||||||||||
Sequence | 53| UGAGGAGAUCGUCGAGGUUGG |73 | ||||||||||||||||||
Evidence | Experimental | ||||||||||||||||||
Experiments | Illumina | ||||||||||||||||||
Editing Events in miRNAs |
|
||||||||||||||||||
SNPs in miRNA |
|
||||||||||||||||||
Putative Targets |
miRNA Expression profile | |
---|---|
Human miRNA Tissue Atlas | |
miRNAs in Extracellular Vesicles |
|
Circulating MicroRNA Expression Profiling |
Gene Information | |||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Gene Symbol | NCOA3 | ||||||||||||||||||||
Synonyms | ACTR, AIB-1, AIB1, CAGH16, CTG26, KAT13B, RAC3, SRC-3, SRC3, TNRC14, TNRC16, TRAM-1, bHLHe42, pCIP | ||||||||||||||||||||
Description | nuclear receptor coactivator 3 | ||||||||||||||||||||
Transcript | NM_001174087 | ||||||||||||||||||||
Other Transcripts | NM_001174088 , NM_006534 , NM_181659 | ||||||||||||||||||||
Expression | |||||||||||||||||||||
Putative miRNA Targets on NCOA3 | |||||||||||||||||||||
3'UTR of NCOA3 (miRNA target sites are highlighted) |
>NCOA3|NM_001174087|3'UTR 1 CATCTCTGCACCAGGACCTCTTAAGGAAACCACTGTACAAATGACACTGCACTAGGATTATTGGGAAGGAATCATTGTTC 81 CAGGCATCCATCTTGGAAGAAAGGACCAGCTTTGAGCTCCATCAAGGGTATTTTAAGTGATGTCATTTGAGCAGGACTGG 161 ATTTTAAGCCGAAGGGCAATATCTACGTGTTTTTCCCCCCTCCTTCTGCTGTGTATCATGGTGTTCAAAACAGAAATGTT 241 TTTTGGCATTCCACCTCCTAGGGATATAATTCTGGAGACATGGAGTGTTACTGATCATAAAACTTTTGTGTCACTTTTTT 321 CTGCCTTGCTAGCCAAAATCTCTTAAATACACGTAGGTGGGCCAGAGAACATTGGAAGAATCAAGAGAGATTAGAATATC 401 TGGTTTCTCTAGTTGCAGTATTGGACAAAGAGCATAGTCCCAGCCTTCAGGTGTAGTAGTTCTGTGTTGACCCTTTGTCC 481 AGTGGAATTGGTGATTCTGAATTGTCCTTTACTAATGGTGTTGAGTTGCTCTGTCCCTATTATTTGCCCTAGGCTTTCTC 561 CTAATGAAGGTTTTCATTTGCCATTCATGTCCTGTAATACTTCACCTCCAGGAACTGTCATGGATGTCCAAATGGCTTTG 641 CAGAAAGGAAATGAGATGACAGTATTTAATCGCAGCAGTAGCAAACTTTTCACATGCTAATGTGCAGCTGAGTGCACTTT 721 ATTTAAAAAGAATGGATAAATGCAATATTCTTGAGGTCTTGAGGGAATAGTGAAACACATTCCTGGTTTTTGCCTACACT 801 TACGTGTTAGACAAGAACTATGATTTTTTTTTTTAAAGTACTGGTGTCACCCTTTGCCTATATGGTAGAGCAATAATGCT 881 TTTTAAAAATAAACTTCTGAAAACCCAAGGCCAGGTACTGCATTCTGAATCAGAATCTCGCAGTGTTTCTGTGAATAGAT 961 TTTTTTGTAAATATGACCTTTAAGATATTGTATTATGTAAAATATGTATATACCTTTTTTTGTAGGTCACAACAACTCAT 1041 TTTTACAGAGTTTGTGAAGCTAAATATTTAACATTGTTGATTTCAGTAAGCTGTGTGGTGAGGCTACCAGTGGAAGAGAC 1121 ATCCCTTGACTTTTGTGGCCTGGGGGAGGGGTAGTGCTCCACAGCTTTTCCTTCCCCACCCCCCAGCCTTAGATGCCTCG 1201 CTCTTTTCAATCTCTTAATCTAAATGCTTTTTAAAGAGATTATTTGTTTAGATGTAGGCATTTTAATTTTTTAAAAATTC 1281 CTCTACCAGAACTAAGCACTTTGTTAATTTGGGGGGAAAGAATAGATATGGGGAAATAAACTTAAAAAAAAATCAGGAAT 1361 TTAAAAAAACGAGCAATTTGAAGAGAATCTTTTGGATTTTAAGCAGTCCGAAATAATAGCAATTCATGGGCTGTGTGTGT 1441 GTGTGTATGTGTGTGTGTGTGTGTGTATGTTTAATTATGTTACCTTTTCATCCCCTTTAGGAGCGTTTTCAGATTTTGGT 1521 TGCTAAGACCTGAATCCCATATTGAGATCTCGAGTAGAATCCTTGGTGTGGTTTCTGGTGTCTGCTCAGCTGTCCCCTCA 1601 TTCTACTAATGTGATGCTTTCATTATGTCCCTGTGGATTAGAATAGTGTCAGTTATTTCTTAAGTAACTCAGTACCCAGA 1681 ACAGCCAGTTTTACTGTGATTCAGAGCCACAGTCTAACTGAGCACCTTTTAAACCCCTCCCTCTTCTGCCCCCTACCACT 1761 TTTCTGCTGTTGCCTCTCTTTGACACCTGTTTTAGTCAGTTGGGAGGAAGGGAAAAATCAAGTTTAATTCCCTTTATCTG 1841 GGTTAATTCATTTGGTTCAAATAGTTGACGGAATTGGGTTTCTGAATGTCTGTGAATTTCAGAGGTCTCTGCTAGCCTTG 1921 GTATCATTTTCTAGCAATAACTGAGAGCCAGTTAATTTTAAGAATTTCACACATTTAGCCAATCTTTCTAGATGTCTCTG 2001 AAGGTAAGATCATTTAATATCTTTGATATGCTTACGAGTAAGTGAATCCTGATTATTTCCAGACCCACCACCAGAGTGGA 2081 TCTTATTTTCAAAGCAGTATAGACAATTATGAGTTTGCCCTCTTTCCCCTACCAAGTTCAAAATATATCTAAGAAAGATT 2161 GTAAATCCGAAAACTTCCATTGTAGTGGCCTGTGCTTTTCAGATAGTATACTCTCCTGTTTGGAGACAGAGGAAGAACCA 2241 GGTCAGTCTGTCTCTTTTTCAGCTCAATTGTATCTGACCCTTCTTTAAGTTATGTGTGTGGGGAGAAATAGAATGGTGCT 2321 CTTATCTTTCTTGACTTTAAAAAAATTATTAAAAACAAAAAAAAAATAAATTTTTTTGCAATCCTTTCCTCAGACCTGGC 2401 TCCAGGCTAACTGGAAGGCAGCACTCCCTTTTTTATATAGTAGAAAAATGAAGTTTATTATAAGTTTTTATATTTTCTAC 2481 TTGTTCATTTGGTGCAAACTCAAGATTTCTTTTAATAGGTGCAGTCTTTGAGATAATTTGTTTTTACCTGTATTGCCCTT 2561 TATCTTTTTTAGGTAATTCTTTGTACTCCTGCTGTCTACCTCTCCTCACACCCCAGCACCCCCCATTTTTTCAAACCTTG 2641 GTATCTGTTGGGTGAACAGTATAATCTTTTCATCTGCTTTTAGAATGTGGGATATTTCCAGTACCTACTTTTTTTTTTTT 2721 TTTTTGCTGAATCCAAAGATATATAAATAAAATATATATATTTTATAAAGATCAGAATGATATAAAGGAGATACATGTTT 2801 CTTCCTTTAAAAAATAAACGGAAGTTACATTGTTAATGTTCATATTATGATGCCACTTTTCTAAACTGCATCTGGATTGA 2881 AAGGTGTAAATATCAATAACAGTGCTACTTAGTTATCAGTATTTAATATCTGAGGTGAGTTGGGGGTATCTATATTAGGG 2961 GTAGGGTATTACAGAAGATAATTGGCTTGATGTCCTAGAAGTTCTTTGATCCAGAGGTGGGTGCAGCTGAAAGTAAACAG 3041 AATGGATTGCCAGTTACATGTATGCCTGCCCAGTTCCCTTTTTATTTGCAGAAGCTGTGAGTTTTGTTCACAATTAGGTT 3121 CCTAGGAGCAAAACCTCAAGGATTGATTTATTGTTTTCAACTCCAAGGCACACTGTTAATAAACGAGCAGGGTGTTTTCT 3201 CTCTTCCTTTCTAATATATGGAGTTTCGAAGAATAAAATATGAGAGCAATATTTAAATTCTCAGGAATTGACTTATACTC 3281 TTGAGAATGAATTCAGTTTCAATCAAGTTTACATTATGTTGCTTAAAAAAATAGAAATTATTCTTTATCTTGCAAAGAAT 3361 TGAAACCACATGAAATGACTTATGGGGGATGGTGAGCTGTGACTGCTTTGCTGACCATTTTGGATGTCATTGTAAATAAA 3441 GGTTTCTATTTAAAATTGGA Target sites
Provided by authors
Predicted by miRanda
DRVs
SNPs
DRVs & SNPs
|
||||||||||||||||||||
miRNA-target interactions (Predicted by miRanda) |
|
||||||||||||||||||||
DRVs in gene 3'UTRs | |||||||||||||||||||||
SNPs in gene 3'UTRs |
Experimental Support 1 for Functional miRNA-Target Interaction | |||||||
---|---|---|---|---|---|---|---|
miRNA:Target | ---- | ||||||
Validation Method |
|
||||||
Conditions | MCF7 | ||||||
Location of target site | 3'UTR | ||||||
Tools used in this research | TargetScan , miRTarCLIP , Piranha | ||||||
Original Description (Extracted from the article) |
...
PAR-CLIP data was present in SRR1045082. RNA binding protein: AGO2. Condition:Untreated
... - Farazi TA; Ten Hoeve JJ; Brown M; et al., 2014, Genome biology. |
||||||
miRNA-target interactions (Provided by authors) |
|
||||||
Article |
- Farazi TA; Ten Hoeve JJ; Brown M; et al. - Genome biology, 2014
BACKGROUND: Various microRNAs (miRNAs) are up- or downregulated in tumors. However, the repression of cognate miRNA targets responsible for the phenotypic effects of this dysregulation in patients remains largely unexplored. To define miRNA targets and associated pathways, together with their relationship to outcome in breast cancer, we integrated patient-paired miRNA-mRNA expression data with a set of validated miRNA targets and pathway inference. RESULTS: To generate a biochemically-validated set of miRNA-binding sites, we performed argonaute-2 photoactivatable-ribonucleoside-enhanced crosslinking and immunoprecipitation (AGO2-PAR-CLIP) in MCF7 cells. We then defined putative miRNA-target interactions using a computational model, which ranked and selected additional TargetScan-predicted interactions based on features of our AGO2-PAR-CLIP binding-site data. We subselected modeled interactions according to the abundance of their constituent miRNA and mRNA transcripts in tumors, and we took advantage of the variability of miRNA expression within molecular subtypes to detect miRNA repression. Interestingly, our data suggest that miRNA families control subtype-specific pathways; for example, miR-17, miR-19a, miR-25, and miR-200b show high miRNA regulatory activity in the triple-negative, basal-like subtype, whereas miR-22 and miR-24 do so in the HER2 subtype. An independent dataset validated our findings for miR-17 and miR-25, and showed a correlation between the expression levels of miR-182 targets and overall patient survival. Pathway analysis associated miR-17, miR-19a, and miR-200b with leukocyte transendothelial migration. CONCLUSIONS: We combined PAR-CLIP data with patient expression data to predict regulatory miRNAs, revealing potential therapeutic targets and prognostic markers in breast cancer.
LinkOut: [PMID: 24398324]
|
Experimental Support 2 for Functional miRNA-Target Interaction | |
---|---|
miRNA:Target | ---- |
Validation Method |
|
Conditions | HCT116 |
Location of target site | 3'UTR |
Tools used in this research | TargetScan , miRTarCLIP , Piranha |
Original Description (Extracted from the article) |
...
PAR-CLIP data was present in ERX177600. RNA binding protein: AGO2. Condition:p53_V_Ago_CLIP_2_2
PAR-CLIP data was present in ERX177606. RNA binding protein: AGO2. Condition:KO_V_AGO_CLIP_2_8
PAR-CLIP data was present in ERX177612. RNA binding protein: AGO2. Condition:p53_V_AGO_CLIP_3_2
PAR-CLIP data was present in ERX177613. RNA binding protein: AGO2. Condition:KO_D_AGO_CLIP_3_3
PAR-CLIP data was present in ERX177618. RNA binding protein: AGO2. Condition:KO_V_AGO_CLIP_3_8
PAR-CLIP data was present in ERX177624. RNA binding protein: AGO2. Condition:p53_V_AGO_CLIP_4_2
PAR-CLIP data was present in ERX177625. RNA binding protein: AGO2. Condition:KO_D_AGO_CLIP_4_3
PAR-CLIP data was present in ERX177630. RNA binding protein: AGO2. Condition:KO_V_AGO_CLIP_4_8
PAR-CLIP data was present in ERX177633. RNA binding protein: AGO2. Condition:KO_D_AGO_CLIP_4_11
... - Krell J; Stebbing J; Carissimi C; Dabrowska et al., 2016, Genome research. |
Article |
- Krell J; Stebbing J; Carissimi C; Dabrowska et al. - Genome research, 2016
DNA damage activates TP53-regulated surveillance mechanisms that are crucial in suppressing tumorigenesis. TP53 orchestrates these responses directly by transcriptionally modulating genes, including microRNAs (miRNAs), and by regulating miRNA biogenesis through interacting with the DROSHA complex. However, whether the association between miRNAs and AGO2 is regulated following DNA damage is not yet known. Here, we show that, following DNA damage, TP53 interacts with AGO2 to induce or reduce AGO2's association of a subset of miRNAs, including multiple let-7 family members. Furthermore, we show that specific mutations in TP53 decrease rather than increase the association of let-7 family miRNAs, reducing their activity without preventing TP53 from interacting with AGO2. This is consistent with the oncogenic properties of these mutants. Using AGO2 RIP-seq and PAR-CLIP-seq, we show that the DNA damage-induced increase in binding of let-7 family members to the RISC complex is functional. We unambiguously determine the global miRNA-mRNA interaction networks involved in the DNA damage response, validating them through the identification of miRNA-target chimeras formed by endogenous ligation reactions. We find that the target complementary region of the let-7 seed tends to have highly fixed positions and more variable ones. Additionally, we observe that miRNAs, whose cellular abundance or differential association with AGO2 is regulated by TP53, are involved in an intricate network of regulatory feedback and feedforward circuits. TP53-mediated regulation of AGO2-miRNA interaction represents a new mechanism of miRNA regulation in carcinogenesis.
LinkOut: [PMID: 26701625]
|
CLIP-seq Support 1 for dataset SRR1045082 | |
---|---|
Method / RBP | PAR-CLIP / AGO2 |
Cell line / Condition | MCF7 / Untreated |
Location of target site | ENST00000341724.6 | 3UTR | UACUCCUGCUGUCUACCUCUCCUCACACCCCAG |
Tools used in this analysis | TargetScan, miRTarCLIP, and Piranha |
Article / Accession Series | PMID: 24398324 / SRX388831 |
CLIP-seq Viewer | Link |
MiRNA-Target Expression Profile | |||||||
---|---|---|---|---|---|---|---|
|
MiRNA-Target Expression Profile (TCGA) | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
182 hsa-miR-3150b-3p Target Genes:
Functional analysis:
ID | Target | Description | Validation methods | |||||||||
Strong evidence | Less strong evidence | |||||||||||
MIRT066803 | ARID1A | AT-rich interaction domain 1A | 2 | 2 | ||||||||
MIRT087964 | TNRC6B | trinucleotide repeat containing 6B | 2 | 4 | ||||||||
MIRT112200 | BTG2 | BTG anti-proliferation factor 2 | 2 | 2 | ||||||||
MIRT115553 | MAZ | MYC associated zinc finger protein | 2 | 2 | ||||||||
MIRT119127 | SPOPL | speckle type BTB/POZ protein like | 2 | 2 | ||||||||
MIRT153910 | NCOA3 | nuclear receptor coactivator 3 | 2 | 2 | ||||||||
MIRT187986 | MBD6 | methyl-CpG binding domain protein 6 | 2 | 2 | ||||||||
MIRT240368 | RAB2A | RAB2A, member RAS oncogene family | 2 | 2 | ||||||||
MIRT249675 | SLC39A9 | solute carrier family 39 member 9 | 2 | 4 | ||||||||
MIRT267540 | C1ORF226 | chromosome 1 open reading frame 226 | 2 | 2 | ||||||||
MIRT282540 | SLCO3A1 | solute carrier organic anion transporter family member 3A1 | 2 | 2 | ||||||||
MIRT319703 | UBN2 | ubinuclein 2 | 2 | 2 | ||||||||
MIRT373666 | POU2F1 | POU class 2 homeobox 1 | 2 | 2 | ||||||||
MIRT390213 | GNAI2 | G protein subunit alpha i2 | 2 | 4 | ||||||||
MIRT444379 | SH3TC2 | SH3 domain and tetratricopeptide repeats 2 | 2 | 2 | ||||||||
MIRT445600 | CAMK2N1 | calcium/calmodulin dependent protein kinase II inhibitor 1 | 2 | 2 | ||||||||
MIRT445635 | TMEM50A | transmembrane protein 50A | 2 | 2 | ||||||||
MIRT447181 | PGRMC2 | progesterone receptor membrane component 2 | 2 | 2 | ||||||||
MIRT447212 | APBB2 | amyloid beta precursor protein binding family B member 2 | 2 | 2 | ||||||||
MIRT447247 | IHH | indian hedgehog | 2 | 2 | ||||||||
MIRT447809 | EMX1 | empty spiracles homeobox 1 | 2 | 2 | ||||||||
MIRT447829 | CTIF | cap binding complex dependent translation initiation factor | 2 | 2 | ||||||||
MIRT449181 | LUC7L3 | LUC7 like 3 pre-mRNA splicing factor | 2 | 2 | ||||||||
MIRT451253 | ZNF444 | zinc finger protein 444 | 2 | 2 | ||||||||
MIRT451378 | C19orf43 | telomerase RNA component interacting RNase | 2 | 2 | ||||||||
MIRT451526 | C16orf58 | chromosome 16 open reading frame 58 | 2 | 2 | ||||||||
MIRT451700 | C1RL | complement C1r subcomponent like | 2 | 2 | ||||||||
MIRT453643 | SLC4A2 | solute carrier family 4 member 2 | 2 | 2 | ||||||||
MIRT454417 | SEPT6 | septin 6 | 2 | 2 | ||||||||
MIRT454636 | FAM83H | family with sequence similarity 83 member H | 2 | 2 | ||||||||
MIRT454889 | RAD50 | RAD50 double strand break repair protein | 2 | 2 | ||||||||
MIRT455298 | BCL2L1 | BCL2 like 1 | 2 | 2 | ||||||||
MIRT455521 | C6orf106 | chromosome 6 open reading frame 106 | 2 | 2 | ||||||||
MIRT455937 | SURF6 | surfeit 6 | 2 | 2 | ||||||||
MIRT456133 | SAMD10 | sterile alpha motif domain containing 10 | 2 | 2 | ||||||||
MIRT456325 | ARHGEF2 | Rho/Rac guanine nucleotide exchange factor 2 | 2 | 2 | ||||||||
MIRT457301 | ZBTB45 | zinc finger and BTB domain containing 45 | 2 | 2 | ||||||||
MIRT457461 | UNC119B | unc-119 lipid binding chaperone B | 2 | 2 | ||||||||
MIRT457533 | ZMAT5 | zinc finger matrin-type 5 | 2 | 2 | ||||||||
MIRT457797 | VWA1 | von Willebrand factor A domain containing 1 | 2 | 2 | ||||||||
MIRT457917 | ZNF212 | zinc finger protein 212 | 2 | 2 | ||||||||
MIRT457936 | LCE1A | late cornified envelope 1A | 2 | 2 | ||||||||
MIRT458914 | DNM2 | dynamin 2 | 2 | 4 | ||||||||
MIRT459075 | WFIKKN2 | WAP, follistatin/kazal, immunoglobulin, kunitz and netrin domain containing 2 | 2 | 2 | ||||||||
MIRT459484 | CCL11 | C-C motif chemokine ligand 11 | 2 | 2 | ||||||||
MIRT459774 | IDH3A | isocitrate dehydrogenase 3 (NAD(+)) alpha | 2 | 2 | ||||||||
MIRT460317 | SH3RF1 | SH3 domain containing ring finger 1 | 2 | 2 | ||||||||
MIRT460697 | RNF157 | ring finger protein 157 | 2 | 2 | ||||||||
MIRT462049 | HOXC13 | homeobox C13 | 2 | 2 | ||||||||
MIRT462156 | IGFBP5 | insulin like growth factor binding protein 5 | 2 | 4 | ||||||||
MIRT463293 | ZFP91 | ZFP91 zinc finger protein | 2 | 2 | ||||||||
MIRT463803 | XPOT | exportin for tRNA | 2 | 2 | ||||||||
MIRT463895 | WNT7B | Wnt family member 7B | 2 | 2 | ||||||||
MIRT463942 | WIZ | widely interspaced zinc finger motifs | 2 | 2 | ||||||||
MIRT464660 | UBE2V1 | ubiquitin conjugating enzyme E2 V1 | 2 | 4 | ||||||||
MIRT465664 | TNPO2 | transportin 2 | 2 | 2 | ||||||||
MIRT465923 | TMEM189-UBE2V1 | TMEM189-UBE2V1 readthrough | 2 | 4 | ||||||||
MIRT466003 | TMEM189 | transmembrane protein 189 | 2 | 4 | ||||||||
MIRT466824 | STX6 | syntaxin 6 | 2 | 6 | ||||||||
MIRT467652 | SLC7A1 | solute carrier family 7 member 1 | 2 | 2 | ||||||||
MIRT467820 | SLC29A2 | solute carrier family 29 member 2 | 2 | 2 | ||||||||
MIRT468743 | SDC2 | syndecan 2 | 2 | 2 | ||||||||
MIRT468793 | SBK1 | SH3 domain binding kinase 1 | 2 | 4 | ||||||||
MIRT469989 | PTPN14 | protein tyrosine phosphatase, non-receptor type 14 | 2 | 2 | ||||||||
MIRT471352 | PEG10 | paternally expressed 10 | 2 | 2 | ||||||||
MIRT472016 | NPTXR | neuronal pentraxin receptor | 2 | 2 | ||||||||
MIRT472255 | NFIC | nuclear factor I C | 2 | 2 | ||||||||
MIRT473114 | MLXIP | MLX interacting protein | 2 | 2 | ||||||||
MIRT473725 | MAPK1 | mitogen-activated protein kinase 1 | 2 | 2 | ||||||||
MIRT474006 | LRRC20 | leucine rich repeat containing 20 | 2 | 2 | ||||||||
MIRT474644 | KLF16 | Kruppel like factor 16 | 2 | 2 | ||||||||
MIRT477420 | EN2 | engrailed homeobox 2 | 2 | 2 | ||||||||
MIRT477724 | EEF1A1 | eukaryotic translation elongation factor 1 alpha 1 | 2 | 2 | ||||||||
MIRT479574 | CDC42SE1 | CDC42 small effector 1 | 2 | 2 | ||||||||
MIRT480428 | C17orf85 | nuclear cap binding subunit 3 | 2 | 2 | ||||||||
MIRT480439 | C17orf49 | chromosome 17 open reading frame 49 | 2 | 2 | ||||||||
MIRT480650 | BSCL2 | BSCL2, seipin lipid droplet biogenesis associated | 2 | 2 | ||||||||
MIRT480984 | BBC3 | BCL2 binding component 3 | 2 | 2 | ||||||||
MIRT481061 | BASP1 | brain abundant membrane attached signal protein 1 | 2 | 2 | ||||||||
MIRT481257 | ATXN7L3 | ataxin 7 like 3 | 2 | 2 | ||||||||
MIRT481494 | ARL6IP1 | ADP ribosylation factor like GTPase 6 interacting protein 1 | 2 | 8 | ||||||||
MIRT482034 | AMER1 | APC membrane recruitment protein 1 | 2 | 2 | ||||||||
MIRT482663 | FAM195B | MAPK regulated corepressor interacting protein 1 | 2 | 4 | ||||||||
MIRT482681 | NXN | nucleoredoxin | 2 | 4 | ||||||||
MIRT482710 | XRCC3 | X-ray repair cross complementing 3 | 2 | 2 | ||||||||
MIRT482835 | GLI4 | GLI family zinc finger 4 | 2 | 2 | ||||||||
MIRT483324 | SLC35C2 | solute carrier family 35 member C2 | 2 | 4 | ||||||||
MIRT483410 | SPATA6 | spermatogenesis associated 6 | 2 | 4 | ||||||||
MIRT483591 | SLC26A9 | solute carrier family 26 member 9 | 2 | 2 | ||||||||
MIRT483781 | CASKIN1 | CASK interacting protein 1 | 2 | 4 | ||||||||
MIRT483819 | CYP2W1 | cytochrome P450 family 2 subfamily W member 1 | 2 | 6 | ||||||||
MIRT483845 | UNC5B | unc-5 netrin receptor B | 2 | 4 | ||||||||
MIRT483972 | ZADH2 | zinc binding alcohol dehydrogenase domain containing 2 | 2 | 2 | ||||||||
MIRT484083 | SUGT1 | SGT1 homolog, MIS12 kinetochore complex assembly cochaperone | 2 | 4 | ||||||||
MIRT484393 | ZNF710 | zinc finger protein 710 | 2 | 4 | ||||||||
MIRT484510 | SYT7 | synaptotagmin 7 | 2 | 2 | ||||||||
MIRT484797 | GPRC5A | G protein-coupled receptor class C group 5 member A | 2 | 2 | ||||||||
MIRT484858 | ZNF70 | zinc finger protein 70 | 2 | 4 | ||||||||
MIRT485397 | MRVI1 | murine retrovirus integration site 1 homolog | 2 | 8 | ||||||||
MIRT485614 | FOSL1 | FOS like 1, AP-1 transcription factor subunit | 2 | 4 | ||||||||
MIRT486168 | TLE3 | transducin like enhancer of split 3 | 2 | 2 | ||||||||
MIRT486228 | NLRP2 | NLR family pyrin domain containing 2 | 2 | 2 | ||||||||
MIRT486249 | FASTK | Fas activated serine/threonine kinase | 2 | 2 | ||||||||
MIRT486296 | KBTBD3 | kelch repeat and BTB domain containing 3 | 2 | 2 | ||||||||
MIRT486384 | TIGD5 | tigger transposable element derived 5 | 2 | 2 | ||||||||
MIRT486474 | TSC22D1 | TSC22 domain family member 1 | 2 | 2 | ||||||||
MIRT486567 | SLC38A4 | solute carrier family 38 member 4 | 2 | 2 | ||||||||
MIRT486615 | METTL6 | methyltransferase like 6 | 2 | 2 | ||||||||
MIRT487499 | IL1F10 | interleukin 1 family member 10 | 2 | 4 | ||||||||
MIRT487520 | GXYLT2 | glucoside xylosyltransferase 2 | 2 | 2 | ||||||||
MIRT487929 | KCND1 | potassium voltage-gated channel subfamily D member 1 | 2 | 2 | ||||||||
MIRT488047 | PABPC1L2B | poly(A) binding protein cytoplasmic 1 like 2B | 2 | 2 | ||||||||
MIRT488063 | PABPC1L2A | poly(A) binding protein cytoplasmic 1 like 2A | 2 | 2 | ||||||||
MIRT488173 | PRRC2B | proline rich coiled-coil 2B | 2 | 4 | ||||||||
MIRT488326 | AFF2 | AF4/FMR2 family member 2 | 2 | 4 | ||||||||
MIRT488925 | GFRAL | GDNF family receptor alpha like | 2 | 2 | ||||||||
MIRT489288 | RBM8A | RNA binding motif protein 8A | 2 | 8 | ||||||||
MIRT489483 | SLITRK5 | SLIT and NTRK like family member 5 | 2 | 2 | ||||||||
MIRT490460 | PROSER2 | proline and serine rich 2 | 2 | 2 | ||||||||
MIRT490563 | TEX261 | testis expressed 261 | 2 | 4 | ||||||||
MIRT490843 | ADD2 | adducin 2 | 2 | 2 | ||||||||
MIRT491355 | CDKN1A | cyclin dependent kinase inhibitor 1A | 2 | 2 | ||||||||
MIRT491455 | HOXB5 | homeobox B5 | 2 | 2 | ||||||||
MIRT491585 | USB1 | U6 snRNA biogenesis phosphodiesterase 1 | 2 | 2 | ||||||||
MIRT492735 | PHF12 | PHD finger protein 12 | 2 | 2 | ||||||||
MIRT493053 | MYO1C | myosin IC | 2 | 4 | ||||||||
MIRT493603 | HMGB3 | high mobility group box 3 | 2 | 6 | ||||||||
MIRT493686 | HAP1 | huntingtin associated protein 1 | 2 | 2 | ||||||||
MIRT493793 | GATA6 | GATA binding protein 6 | 2 | 2 | ||||||||
MIRT493881 | FAM73B | mitoguardin 2 | 2 | 4 | ||||||||
MIRT494238 | CHAC1 | ChaC glutathione specific gamma-glutamylcyclotransferase 1 | 2 | 2 | ||||||||
MIRT494512 | BDNF-AS | BDNF antisense RNA | 2 | 2 | ||||||||
MIRT494717 | ARHGAP31 | Rho GTPase activating protein 31 | 2 | 2 | ||||||||
MIRT494907 | UCP2 | uncoupling protein 2 | 2 | 2 | ||||||||
MIRT498832 | ZNF561 | zinc finger protein 561 | 2 | 2 | ||||||||
MIRT498921 | SRCAP | Snf2 related CREBBP activator protein | 2 | 2 | ||||||||
MIRT498949 | IKBKG | inhibitor of nuclear factor kappa B kinase subunit gamma | 2 | 2 | ||||||||
MIRT499551 | C15orf43 | telomere repeat binding bouquet formation protein 2 | 2 | 2 | ||||||||
MIRT501370 | REXO1 | RNA exonuclease 1 homolog | 2 | 4 | ||||||||
MIRT511910 | FKBP1A | FK506 binding protein 1A | 2 | 2 | ||||||||
MIRT512594 | ZNF783 | zinc finger family member 783 | 2 | 2 | ||||||||
MIRT513339 | CDK2 | cyclin dependent kinase 2 | 2 | 4 | ||||||||
MIRT513729 | PSD3 | pleckstrin and Sec7 domain containing 3 | 2 | 4 | ||||||||
MIRT527702 | IL17REL | interleukin 17 receptor E like | 2 | 2 | ||||||||
MIRT533488 | TRIM71 | tripartite motif containing 71 | 2 | 2 | ||||||||
MIRT533680 | TMEM86A | transmembrane protein 86A | 2 | 2 | ||||||||
MIRT534167 | SLC8A1 | solute carrier family 8 member A1 | 2 | 2 | ||||||||
MIRT537885 | EDA2R | ectodysplasin A2 receptor | 2 | 2 | ||||||||
MIRT538548 | CELF1 | CUGBP Elav-like family member 1 | 2 | 2 | ||||||||
MIRT552014 | RAD18 | RAD18, E3 ubiquitin protein ligase | 2 | 2 | ||||||||
MIRT555336 | PPP1R3B | protein phosphatase 1 regulatory subunit 3B | 2 | 4 | ||||||||
MIRT565155 | TUBB2A | tubulin beta 2A class IIa | 2 | 2 | ||||||||
MIRT568712 | TMEM30B | transmembrane protein 30B | 2 | 2 | ||||||||
MIRT568824 | TRIM67 | tripartite motif containing 67 | 2 | 2 | ||||||||
MIRT569459 | PIGP | phosphatidylinositol glycan anchor biosynthesis class P | 2 | 2 | ||||||||
MIRT569589 | PRELP | proline and arginine rich end leucine rich repeat protein | 2 | 2 | ||||||||
MIRT569619 | ASTN2 | astrotactin 2 | 2 | 2 | ||||||||
MIRT569826 | CRMP1 | collapsin response mediator protein 1 | 2 | 2 | ||||||||
MIRT569985 | TMEM184A | transmembrane protein 184A | 2 | 2 | ||||||||
MIRT570066 | CPNE2 | copine 2 | 2 | 2 | ||||||||
MIRT570540 | RPH3A | rabphilin 3A | 2 | 2 | ||||||||
MIRT570729 | CELSR2 | cadherin EGF LAG seven-pass G-type receptor 2 | 2 | 2 | ||||||||
MIRT570797 | CKAP2L | cytoskeleton associated protein 2 like | 2 | 2 | ||||||||
MIRT570898 | METTL21A | methyltransferase like 21A | 2 | 2 | ||||||||
MIRT570944 | CPE | carboxypeptidase E | 2 | 2 | ||||||||
MIRT570964 | TMBIM4 | transmembrane BAX inhibitor motif containing 4 | 2 | 2 | ||||||||
MIRT571169 | ZNF85 | zinc finger protein 85 | 2 | 2 | ||||||||
MIRT573015 | RPP25 | ribonuclease P and MRP subunit p25 | 2 | 2 | ||||||||
MIRT573673 | HES6 | hes family bHLH transcription factor 6 | 2 | 2 | ||||||||
MIRT574812 | EIF1 | eukaryotic translation initiation factor 1 | 2 | 2 | ||||||||
MIRT576755 | Tmem127 | transmembrane protein 127 | 2 | 2 | ||||||||
MIRT618157 | CHCHD5 | coiled-coil-helix-coiled-coil-helix domain containing 5 | 2 | 2 | ||||||||
MIRT643640 | EZH2 | enhancer of zeste 2 polycomb repressive complex 2 subunit | 2 | 2 | ||||||||
MIRT649084 | CACNA1B | calcium voltage-gated channel subunit alpha1 B | 2 | 2 | ||||||||
MIRT658378 | FAM53C | family with sequence similarity 53 member C | 2 | 2 | ||||||||
MIRT667955 | HMGCS1 | 3-hydroxy-3-methylglutaryl-CoA synthase 1 | 2 | 2 | ||||||||
MIRT691696 | FLOT2 | flotillin 2 | 2 | 2 | ||||||||
MIRT697545 | ZBTB44 | zinc finger and BTB domain containing 44 | 2 | 2 | ||||||||
MIRT701530 | NDEL1 | nudE neurodevelopment protein 1 like 1 | 2 | 2 | ||||||||
MIRT705766 | ALG14 | ALG14, UDP-N-acetylglucosaminyltransferase subunit | 2 | 2 | ||||||||
MIRT715222 | NPVF | neuropeptide VF precursor | 2 | 2 | ||||||||
MIRT719548 | CBLB | Cbl proto-oncogene B | 2 | 2 |
miRNA-Drug Resistance Associations | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|